These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1863271)

  • 1. The edema inducing activity of phospholipase A2 enzymes.
    Tan NH; Saifuddin MN; Yong WY
    Biochem Int; 1991 Jan; 23(1):175-81. PubMed ID: 1863271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of crotapotin and heparin on the rat paw oedema induced by different secretory phospholipases A2.
    Landucci EC; Toyama M; Marangoni S; Oliveira B; Cirino G; Antunes E; de Nucci G
    Toxicon; 2000 Feb; 38(2):199-208. PubMed ID: 10665801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human type II phospholipase A2 lacks edema producing activity in rat.
    Morgan DW; Anderson CM; Meyers KP
    Eur J Pharmacol; 1993 Apr; 235(1):45-50. PubMed ID: 8519280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oedema formation and degranulation of mast cells by phospholipase A2 purified from porcine pancreas and snake venoms.
    Lloret S; Moreno JJ
    Toxicon; 1993 Aug; 31(8):949-56. PubMed ID: 8212047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edema formation and degranulation of mast cells by a basic phospholipase A2 purified from Trimeresurus mucrosquamatus snake venom.
    Chiu HF; Chen IJ; Teng CM
    Toxicon; 1989; 27(1):115-25. PubMed ID: 2469141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents.
    Marshall LA; Chang JY; Calhoun W; Yu J; Carlson RP
    J Cell Biochem; 1989 Jun; 40(2):147-55. PubMed ID: 2768346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat paw oedema and mast cell degranulation caused by two phospholipase A2 enzymes isolated from Trimeresurus mucrosquamatus venom.
    Wang JP; Teng CM
    J Pharm Pharmacol; 1990 Dec; 42(12):846-50. PubMed ID: 1713267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic modulation of D-49 phospholipase A2-induced paw edema in the mouse.
    Calhoun W; Yu J; Sung A; Chau TT; Marshall LA; Weichman BM; Carlson RP
    Agents Actions; 1989 Jun; 27(3-4):418-21. PubMed ID: 2801333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of PMN leucocytes, platelets and some mediators in rat hind-paw oedema induced by two phospholipase A2 enzymes from Trimeresurus mucrosquamatus venom.
    Wang JP; Teng CM
    J Pharm Pharmacol; 1992 Apr; 44(4):300-5. PubMed ID: 1355540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction.
    Ticli FK; Hage LI; Cambraia RS; Pereira PS; Magro AJ; Fontes MR; Stábeli RG; Giglio JR; França SC; Soares AM; Sampaio SV
    Toxicon; 2005 Sep; 46(3):318-27. PubMed ID: 15992846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid.
    Vishwanath BS; Kini RM; Gowda TV
    Toxicon; 1987; 25(5):501-15. PubMed ID: 3617087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the enzymatic and edema-producing activities of two venom phospholipase A2 enzymes.
    Wang JP; Teng CM
    Eur J Pharmacol; 1990 Nov; 190(3):347-54. PubMed ID: 1703083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo).
    Chaves F; León G; Alvarado VH; Gutiérrez JM
    Toxicon; 1998 Dec; 36(12):1861-9. PubMed ID: 9839670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of morin on snake venom phospholipase A2 (PLA2).
    Iglesias CV; Aparicio R; Rodrigues-Simioni L; Camargo EA; Antunes E; Marangoni S; de Oliveira Toyama D; Beriam LO; Monteiro HS; Toyama MH
    Toxicon; 2005 Dec; 46(7):751-8. PubMed ID: 16185736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model to explain the pharmacological effects of snake venom phospholipases A2.
    Kini RM; Evans HJ
    Toxicon; 1989; 27(6):613-35. PubMed ID: 2665186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thielocin A1 beta on bee venom phospholipase A2-induced edema in mouse paw.
    Tanaka K; Matsutani S; Matsumoto K; Yoshida T
    Eur J Pharmacol; 1995 Jun; 279(2-3):143-8. PubMed ID: 7556394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chlorpromazine on the enzymatic and toxic properties of the most basic phospholipase A2 from Vipera russelli snake venom.
    Babu AS; Gowda TV
    Inflamm Res; 1995 Aug; 44(8):340-4. PubMed ID: 8581521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of two phospholipase A2 inhibitors on the neuromuscular blocking activities of homologous phospholipases A2 from the venom of Pseudechis australis, the Australian king brown snake.
    Fatehi M; Rowan EG; Harvey AL
    Toxicon; 1995 Dec; 33(12):1633-43. PubMed ID: 8866620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of two acidic phospholipase A2 enzymes from king cobra (Ophiophagus hannah) snake venom.
    Tan NH; Saifuddin MN
    Int J Biochem; 1990; 22(5):481-7. PubMed ID: 2347427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2.
    Pereañez JA; Patiño AC; Núñez V; Osorio E
    Chem Biol Interact; 2014 Sep; 220():94-101. PubMed ID: 24995575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.